EDSA
Edesa Biotech, Inc.
There isn't enough reported data to score EDSA yet.
LLY
Eli Lilly and Company
LLY's fundamentals are strong: revenue grew 46% and it turned 23% of its revenue into free cash flow. At 46x earnings, it's trading in line with its usual 48x. Analysts expect that strong growth to continue.
EDSA Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Unavailable | |
| Unavailable |
EDSA's revenue and profitability are currently weak. There isn't enough data to rate its cash flow and balance sheet.
LLY Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Healthy |
LLY's revenue, profitability, cash flow and balance sheet are all currently healthy.
EDSA PE Valuation
EDSA has no meaningful PE right now: it lost money over the past year.
LLY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $845 | -41% |
| Forward | 30x | $1,427 | — |
| Current | 46x | $1,427 | — |
| Fair | 48x | $1,466 | +2.7% |
| Expensive | 85x | $2,612 | +83% |
Historical ranges are pointers, not guarantees.
LLY's PE is in its fair range at 46x. If earnings grow as analysts expect, today's price would be 30x next year's earnings, in its cheap range.
EDSA Forward outlook
There aren't enough analyst estimates for EDSA to show an outlook.
LLY Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for LLY, with profitability improving.
EDSA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.61 | -$0.28 |
| Q1 2026 | -$1.26 | +$0.34 |
| Q4 2025 | -$1.07 | +$0.81 |
| Q3 2025 | -$1.27 | +$0.66 |
| Q2 2022 | -$9.03 | -$1.82 |
| Q1 2022 | -$8.93 | -$2.84 |
| Q4 2021 | -$8.19 | -$2.24 |
| Q3 2021 | -$7.70 | -$2.52 |
EDSA is still losing money, but far less than before: $1.61 per share over the past year, against $26.92 at its worst in late 2019.
LLY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $46.82 | +52% |
| Q3 2026 | $30.81 | +51% |
| Q2 2026 | $29.80 | +95% |
| Q1 2026 | $28.15 | +129% |
| Q4 2025 | $22.95 | +96% |
| Q3 2025 | $20.44 | +121% |
| Q2 2025 | $15.30 | +88% |
| Q1 2025 | $12.29 | +81% |
| Q4 2024 | $11.71 | +102% |
LLY has the edge over EDSA on earnings quality, reporting a profit while its opponent remains loss making.
EDSA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2020 | $500 | -100% |
LLY has the stronger quarterly revenue trend. Revenue is down 100% for EDSA versus up 39% for LLY.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2020 | -402095% | -401858 points |
| Q2 2020 | -1608% | N/A |
| Q1 2020 | -1372% | N/A |
| Q4 2019 | -1026% | N/A |
| Q3 2019 | -237% | N/A |
EDSA's operating margin was −402095% last quarter, down 401858 points from the same quarter a year ago, near the bottom of its range since 2019.
LLY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.4B | +39% |
| Q2 2026 | $23B | +48% |
| Q1 2026 | $19.8B | +56% |
| Q4 2025 | $19.3B | +43% |
| Q3 2025 | $17.6B | +54% |
| Q2 2025 | $15.6B | +38% |
| Q1 2025 | $12.7B | +45% |
| Q4 2024 | $13.5B | +45% |
LLY's revenue has grown year over year for 14 quarters in a row: $24.4B last quarter, up 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 34% | -6.6 points |
| Q2 2026 | 40% | -3.3 points |
| Q1 2026 | 45% | +18 points |
| Q4 2025 | 43% | +5.6 points |
| Q3 2025 | 41% | +27 points |
| Q2 2025 | 44% | +12 points |
| Q1 2025 | 27% | -1.8 points |
| Q4 2024 | 37% | +10 points |
LLY's operating margin was 34% last quarter, down 6.6 points from the same quarter a year ago.
EDSA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.1M | -$1.4M |
| Q1 2026 | -$2M | +$366.7K |
| Q4 2025 | -$2.1M | -$570.1K |
| Q3 2025 | -$1.7M | -$754K |
| Q2 2025 | -$1.7M | -$844.3K |
| Q1 2025 | -$2.4M | -$723.1K |
| Q4 2024 | -$1.5M | -$110.7K |
| Q3 2024 | -$967K | +$501K |
EDSA has burned cash in almost every quarter: −$9M over the past year, against −$7M the year before.
LLY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $8.2B | +22% |
| Q2 2026 | $7.8B | +458% |
| Q1 2026 | $3B | +1826% |
| Q4 2025 | $677.9M | -31% |
| Q3 2025 | $6.7B | +186% |
| Q2 2025 | $1.4B | +476% |
| Q1 2025 | $156.1M | -13% |
| Q4 2024 | $977.8M | +$2.4B |
LLY has the edge over EDSA on cash generation, producing positive trailing cash flow while its opponent burns cash.
EDSA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.5% | +466K shares |
| 1 year | +70% | +3.7M shares |
| 3 years | +206% | +6.1M shares |
| 5 years | +442% | +7.3M shares |
| Available history | +735% | +7.9M shares |
EDSA has 9M diluted shares, up 70% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2019 | — |
LLY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -300K shares |
| 1 year | -0.6% | -5.4M shares |
| 3 years | -0.7% | -6.4M shares |
| 5 years | -1.9% | -17.4M shares |
| Available history | -4.5% | -42.3M shares |
LLY has the edge over EDSA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $377M |
| Q2 2026 | $1.6B |
| Q1 2026 | $2.4B |
| Q4 2025 | $1.5B |
| Q3 2025 | $708.1M |
| Q2 2025 | $692.2M |
| Q1 2025 | $1.2B |
| Q4 2024 | $2.1B |
LLY spent $5.8B buying back its own shares over the past year, up 26% from the year before.
EDSA Net Leverage
EDSA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LLY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.2x | Healthy |
| Q2 2026 | 1.3x | Healthy |
| Q1 2026 | 1.2x | Healthy |
| Q4 2025 | 1.3x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 2.0x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
LLY's net debt is about 1.2 years of its operating earnings (EBITDA), about the same as a year ago.
EDSA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 35.3 | Neutral |
| Stochastic | 3.4 | Oversold |
EDSA's weekly RSI is 35 (neutral) and its Stochastic is 3 (oversold).
LLY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.3 | Neutral |
| Stochastic | 84.1 | Overbought |
LLY's weekly RSI is 68 (neutral) and its Stochastic is 84 (overbought).
EDSA PE vs Healthcare Sector
EDSA has no meaningful PE right now: it lost money over the past year.
LLY PE vs Healthcare Sector
| Metric | LLY | Sector median | Relative |
|---|---|---|---|
| PE | 46x | 26x | 79% above |
| PE % | 48 | 29 | 19 pts above |
LLY is trading at 46x earnings, a 79% premium to the Healthcare sector's median of 26x.
EDSA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.94 | 29% below |
| 20 week MA | $4.39 | 53% below |
| 50 week MA | $4.97 | 58% below |
| 100 week MA | $3.57 | 42% below |
| 200 week MA | $4.39 | 53% below |
EDSA is in a downtrend: it's below all five of its weekly moving averages, and 53% below its 200-week average.
LLY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,279.4 | 12% above |
| 20 week MA | $1,218.8 | 17% above |
| 50 week MA | $1,102.2 | 29% above |
| 100 week MA | $954.1 | 50% above |
| 200 week MA | $797.5 | 79% above |
LLY has the edge over EDSA on trend strength, trading above more of its moving averages.
EDSA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.4 | $33.5 | +18% |
| 2021 | $33.5 | $45.3 | +35% |
| 2022 | $45.3 | $14.8 | -67% |
| 2023 | $14.8 | $4.57 | -69% |
| 2024 | $4.57 | $1.85 | -60% |
| 2025 | $1.85 | $1.44 | -22% |
| 2026 YTD | $1.44 | $2.08 | +44% |
EDSA has the edge over LLY on returns for 2026, with the stronger performance.
LLY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $131.5 | $166.7 | +27% |
| 2021 | $166.7 | $273.1 | +64% |
| 2022 | $273.1 | $367.9 | +35% |
| 2023 | $367.9 | $582.9 | +58% |
| 2024 | $582.9 | $783.2 | +34% |
| 2025 | $783.2 | $1,077.8 | +38% |
| 2026 YTD | $1,077.8 | $1,427.3 | +32% |
LLY has finished every year since 2020 higher, and it's up 32% so far in 2026.